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INTRODUCTION
Adverse Drug Reactions (ADRs) constitute an
important cause of morbidity and mortality affecting
all age groups. An ADR is any noxious, unintended
and undesired effect of a drug, which occurs at doses
normally used in humans for prophylaxis, diagnosis,
or therapy of disease or the modification of
physiological functions.1 It is known that ADR may
occur with any drug even when used correctly.2
However, certain factors may predispose or contribute
to development of ADR and these may include:
irrational use of drugs and poor prescribing patterns;
promotional activities by pharmaceutical company;
inadequate access to objective sources of  information;
liberal drug outlets and unhealthy pharmaceutical
practices; self-medication practices; “drug gifts” from
overseas; lack of public awareness and low literacy
level .3
The burden of ADRs is borne by all populations and
throughout the world is expected to be higher in
developing countries because of  ignorance, poverty,
self-medication and increase prevalence of fake and
adulterated medicines.4 The economic burden of
ADRs on the society is enormous, for example, in the
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ABSTRACT
Background: Adverse drug reactions, (ADRs), constitute an important
cause of morbidity and mortality worldwide. Spontaneous adverse drug
reaction (ADR) reporting is the bedrock of  post-marketing surveillance
but under-reporting remains its major drawback.
Objectives: This study aimed at evaluating the attitude and practice
of  ADR among doctors in a tertiary health facility in Oyo State,
Nigeria, with a view to improving ADRs reporting.
Methods: This was a cross-sectional questionnaire based study
involving medical doctors working at the Ladoke Akintola University
of  Technology (LAUTECH) Teaching Hospital, Ogbomoso.
Consenting doctors were evaluated on their attitude and practice of
ADRs through self-administered questionnaire. Data obtained were
entered and analyzed using SPSS version 17.
Results: A total of 35 doctors responded to the questionnaires. Only
about 57.1% considered ADR before prescribing, all of whom were
also aware of  the procedure for reporting. Awareness of  the existence
of  National Pharmacovigilance Center (NPC) was 71.4%. Thirty
(85.7%) of the respondents have encountered ADR, but only 2.9%
have ever reported it with yellow form. Majority (85.7%) of  the
respondents did not consider ADR reporting as a useful tool in the
prevention of drug related morbidities and mortalities. Other factors
that may hinder ADR reporting include: lack of awareness of the
existence of  yellow forms for reporting (68.6%) and poor knowledge
of procedure for reporting (48.6%).
Conclusion: ADR reporting rate was very low among the participants
in this small study; large studies aimed at evaluating the determinants
of ADR reporting should be considered. Should these findings be
confirmed, training and re-retraining through Continuing Medical
Education (CME), and establishment of  pharmacovigilance committee
would be required to ensure a national pharmaovigilance system.
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ORIGINAL ARTICLE
US, an estimated annual cost of  drug-related problems
is 30 billion Dollars.5
Consequent upon the thalidomide disaster, drugs are
only approved for the use of humans after they have
been properly evaluated and found to be safe.  This
pre-marketing evaluation of drugs has some major
drawbacks: there is under-estimation as  adverse drug
reactions with incidence of less than 1% are frequently
not identified; there is selection bias imposed by the
standard protocols of clinical trials; and there is
incomplete or lack of  information on chronic toxicity.6,7
Post-marketing surveillance is a very important tool
for ensuring safety of drugs and complements the
clinical drug evaluation done before approval. It is
instructive that when drugs are administered to all
populations the probability of adverse and other drug-
related problems will manifest more easily than during
the clinical evaluation stages. Pharmacovigilance is the
science and activities relating to the detection,
assessment, understanding and prevention of adverse
drug reactions or any other drug related problem.7
The role of medical doctors is vital in recording and
reporting suspected ADRs in order that regulatory
agencies are alerted of emerging safety concerns and
thereby facilitating timely and appropriate action.
Evaluating the attitude and practice of doctors may




The study was conducted at LAUTECH Teaching
Hospital, Ogbomoso, Nigeria. The hospital provides
medical services to communities in Oyo and the
neighbouring Kwara and Osun States. Presently, the
hospital does not have a consultant grade Clinical
Pharmacologist and pharmacovigilance committee.
Design and data collection
This was a cross-sectional study involving doctors who
were surveyed with a questionnaire. The self-
administered questionnaire sought details of biosocial
information of  the consenting doctors and the
elements of  attitude and practice of  ADRs.
Data analysis
Data obtained were entered into SPSS version 17
software for analysis. The results were presented as
mean  standard deviation for quantitative variable
and numbers with percentages for categorical variables.
Tests of  association between categorical variables were
determined with the Fisher’s exact test and continuous
variables with student’s t-test. A p-value of  less than
0.05 was considered statistically significant.
RESULTS
Thirty-five consented medical doctors participated in
the study. The mean age of  the respondents was
32.1+4.7years.Only 8 respondents were females
whereas the remaining 27 were males. The mean years
of practice was 5.9 years, and majority of respondents
26 (74.3%) had practised for between 3-6 years. More
than one-quarter of the respondents were in family
medicine, 10 (28.6%), Internal medicine, 5 (14.3%),
Surgery, 2 (5.7%), Paediatrics, 4 (11.4%), Obstetrics
Variable                                         Response
Gender
Male                                     27(77.1%)
Female                                 8(22.9%)
Age
Mean 32.1 ± 4.
Year of experience
Mean                                       5.9 ±2.5
Table 1: Demographic data of  the respondents











Total 1 34 35
Table 2: Relationship between the cadre of  respondents and
reporting of suspected ADR with yellow form
and Gynaecology, 5 (14.4%), Psychiatry, 2 (5.7%),
Ophthalmology, 2 (5.7%), Laboratory Medicine, 3
(8.6%) and others who did not indicate their specialty,
2 (5.7%). More than three-quarter of the respondents
27 (77.1%) were Registrars, 2(5.7%) were Senior
Registrars and 6(17.2%) were Consultants.
Majority of the respondents, 30 (85.7%) agreed that
ADR constitute an important problem in medical
practice but only 20 or 57.1%  of all the respondents
Specialties Yes No
Family medicine 0(0.0%) 10(100.0%)
Internal medicine 0(0.0%) 5(100.0%)
Surgery 0(0.0%) 2(100.0%)
Paediatrics 0(0.0%) 4(100.0%)
Obs. & Gyn 0(0.0%) 5(100.0%)
Psychiatry 0(0.0%) 2(100.0%)
Ophthalmology 0(0.0%) 2(100.0%)
Laboratory medicine 1(33.3%) 2(66.7%)
Others 0(0.0%) 2(100.0%)
Table 3: Relationship between the specialties of  the
respondents and reporting of suspected ADR with yellow
form
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considered ADR before prescribing for patients. The
awareness of procedure for ADR reporting was low
among respondents, 17 (48.6%). Majority 25 (71.4%)
of the respondents were aware of the National
Pharmacovigilance Center (NPC) but only 20 (57.1%)
were aware of  the ADR form and procedure. Thirty
respondents (85.7%) have observed a suspected ADR
in their practice but only 1 (2.9%) have ever reported
it with yellow form. Respondents’ views on  factors
that may hinder ADR reporting were: not knowing
ADR should be reported 4 (11.4%), information on
ADR is not useful 30 (85.7%), not sure of the type of
ADR to report 10 (28.6%),  lack of awareness of the
forms for reporting 24 (68.6%), complexity and time-
consuming ADR form 3 (8.6%), uncertainty about
reaction related to drug 17 (48.6%), fear of litigation
5 (14.3%), lack of remuneration (11.4%), report
generate extra work 6 (17.1%), lack of time to actively
look for ADR while at work 8 (22.9%) and the negative
impact the reporting will have on the drug
manufacturer 4 (11.4%). In all, 31(88.6%) of the
respondents agreed that ADR reporting is a
professional obligation. There was no statistically
significant relationship between respondents’ cadre and
reporting of  ADRs with yellow form as shown in
table 2 (p =0.829). The respondents’ specialties and
reporting of  suspected ADRs with yellow form is
shown in table 3. Only 3 (8.6%) respondents have been
trained on how to report ADR.
Suggested ways of  improving ADR reporting were:
training on ADR reporting and increase awareness
through the Continuing Medical Education (CME) 10
(28.6%);  training and retraining of medical personnel
6 (17.1%); making yellow forms readily available in
the hospital  4 (11.4%); setting up a pharmacovigilance
committee 3(8.6%); increase awareness of ADR
reporting through public lecture and mass media
publicity 3 (8.6%); inclusion of  the pharmacovigilance
training in undergraduate and postgraduate training
curriculum 1(2.9%); incorporation of the training into
pre-employment orientation programme 1(2.9%).
DISCUSSION
In this study, less than 60% of  the consenting physicians
returned the questionnaire though, the response rate
was similar to an earlier report in Nigeria.8 Of the
respondents, consultants constituted 17.2%, an
impressive proportion, given the fact that consultants
are rarely invited to participate in such surveys. Majority
of the respondents appreciated the importance of
ADR in medical practice but fewer of them actualize
such appreciation in their practice. The reason was not
immediately obvious but the lack of emphasis of
pharmacovigilance in the undergraduate and
postgraduate medical curricula may have contributed.
Other possible reasons may include: poor knowledge
of the procedure for reporting and lack of awareness
of  the existence of  yellow forms for reporting.8
The level of awareness of ADR reporting process
was low and was similar to findings from similar studies
in Nigeria,8-13 thus suggesting major information gaps.
The study center was just established with no
pharmacovigilance committee and no programme on
ground for ADRs reporting. This may be responsible
for the respondents’ low level of  awareness. It is
interesting to note that Awodele et al.14 reported a
dissimilar finding in a study that involved doctors in
private hospitals in Lagos. No immediate reason(s)
could be proffered for this but an interaction of the
environment, the attitude and awareness of patients
may be a possible explanation.
Majority of the respondents in this study indicated their
willingness to undergo training in pharmacovigilance
and have suggested increased awareness through the
continuing medical education (CME). In addition,
Suggest possible ways of improving ADR reporting Number of
respondents
Percentage
Increase awareness via CME
Inclusion in the under- and post-graduate training curriculum
Yellow forms for reporting must be readily available
Training and retraining of medical personnel
Lecture and publicity
Incorporate it into employment procedure
Set up pharmacovigilance team in hospital and



















Table 4: Suggested ways of  improving ADR reporting
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respondents would like the inclusion of
pharmacovigilance in the undergraduate and
postgraduate training of doctors and the establishment
of  functional pharmacovigilance committee in the
hospitals.
CONCLUSION
ADR reporting rate was very low in this study. That
the respondents practice in a tertiary health facility and
are mainly undergoing postgraduate medical training
should raise serious concerns.  However, larger well
designed epidemiological studies should be considered,
and if  these findings are confirmed efforts should be
geared towards addressing the poor attitude and
practice of  pharmaovigilance among medical
practitioners.
LIMITATION OF THE STUDY
The study population was small and may be difficult
to be generalized, and the responses of the participants
may also have been biased since the information
obtained was not validated.
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